Antineoplastic Combined Chemotherapy ProtocolsDoxorubicinChemotherapy, AdjuvantCyclophosphamideCombined Modality TherapyAntineoplastic AgentsEtoposideCisplatinTreatment OutcomeVinblastineMethotrexateAntineoplastic Agents, PhytogenicBleomycinLomustineDisease-Free SurvivalDrug Administration ScheduleSurvival AnalysisNeoplasm StagingSurvival RateLymphoma, Non-HodgkinNeoadjuvant TherapyPrognosisVinca AlkaloidsIfosfamideLung NeoplasmsDrug Resistance, NeoplasmCytarabineBreast NeoplasmsPaclitaxelCarboplatinDaunorubicinAntibodies, Monoclonal, Murine-DerivedHodgkin DiseaseP-GlycoproteinNeoplasm Recurrence, LocalDacarbazineAsparaginaseMelphalanLymphoma, Large B-Cell, DiffusePrednisoloneDrug ResistancePrecursor Cell Lymphoblastic Leukemia-LymphomaDrug Resistance, MultipleInduction ChemotherapyAntibiotics, AntineoplasticAntineoplastic Agents, AlkylatingFollow-Up StudiesCarmustineTaxoidsSalvage TherapyRhabdomyosarcomaMitoxantroneVindesineLeukemia P388Time FactorsBrain NeoplasmsNeoplasmsTransplantation, AutologousAntimetabolites, AntineoplasticDexamethasoneNeutropeniaDose-Response Relationship, DrugOrganoplatinum CompoundsOligodendrogliomaAnthracyclinesRadiotherapy, AdjuvantClinical Trials as TopicDeoxycytidineNeoplasm MetastasisDactinomycinGranulocyte Colony-Stimulating FactorRadiotherapyTesticular NeoplasmsLymphomaProspective StudiesLeukopeniaRecurrenceNimustineInfusions, IntravenousNauseaMultiple MyelomaOvarian NeoplasmsVomitingChlorambucilBone NeoplasmsChemotherapy, Cancer, Regional PerfusionTeniposideKaplan-Meier EstimateCell Line, TumorCarcinoma, Non-Small-Cell LungAdenocarcinomaRemission InductionCamptothecinDrug Screening Assays, AntitumorTumor Cells, CulturedNeoplasms, Germ Cell and EmbryonalSarcoma, EwingLeukemia, LymphoidRadiotherapy DosageThrombocytopenia